Publications (62) Alfonso Jesús Domínguez-Gil Hurlé publications

filter_list Pharmacology

2022

  1. Iniciación a la toxicocinética desde la Real Academia Nacional de Farmacia: Un ejemplo de colaboración académica

    Anales de la Real Academia Nacional de Farmacia, Núm. 5, pp. 455-468

2009

  1. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients

    Journal of Pharmacy and Pharmacology, Vol. 61, Núm. 6, pp. 759-766

2007

  1. Diccionario terminológico de las ciencias farmacéuticas

    Ariel España

  2. Disposition of linezolid in the isolated rat lung after systemic and pulmonary drug delivery

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 5, pp. 1074-1079

  3. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain

    Clinical Drug Investigation, Vol. 27, Núm. 3, pp. 197-205

2006

  1. Farmacocinética y seguridad del paciente: discurso para la recepción del Académico Electo Alfonso Domínguez-Gil Hurlé y contestación de Jesús San Miguel Izquierdo

    Real Academia de Medicina de Salamanca

  2. Neobrufen efervescente®: Una mejor respuesta analgésica

    DOLOR, Vol. 21, Núm. 1, pp. 28-37

2005

  1. Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients

    Clinical Pharmacokinetics, Vol. 44, Núm. 6, pp. 627-635

2004

  1. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates

    Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 1, pp. 193-198

1997

  1. Influence of route of administration and dosage form in the pharmacokinetic and bioavailability of salbutamol

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 22, Núm. 2, pp. 145-150

  2. Study on pharmacokinetics and nephrotoxicity of netilmicin in rabbits using a new dosage regimen

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 19, Núm. 1, pp. 53-59

1996

  1. Correlation of 'in vitro' release and 'in vivo' absorption characteristics of four salbutamol sulphate formulations

    International Journal of Pharmaceutics, Vol. 139, Núm. 1-2, pp. 45-52

  2. FARMACOCINETICA CLINICA DE LOS INHIBIDORES SELECTIVOS DE LA RECAPTACION DE SEROTONINA

    Farmacia Hospitalaria, Vol. 20, Núm. 2, pp. 73-85

1994

  1. Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin

    Journal of Antimicrobial Chemotherapy, Vol. 34, Núm. 1, pp. 119-125

1992

  1. A method for the calculation of bioavailability in slow release formulations in the presence of within-individual variability

    International Journal of Pharmaceutics, Vol. 86, Núm. 2-3, pp. 123-130

  2. Influence of length of treatment on the interaction between phenobarbital and phenytoin

    Journal of Clinical Pharmacy and Therapeutics, Vol. 17, Núm. 1, pp. 49-50

  3. SIGNIFICACION CLINICA DE LA INTERACCION FLUOROQUINOLONAS-TEOFILINA

    Revista Espanola de Quimioterapia, Vol. 5, Núm. 2, pp. 111-119

1991

  1. Bioequivalence of a new formulation of flecainide acetate.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 216-220

  2. Pharmacokinetics of cefazoline and dibenzylamine administered in a sustained drug delivery system to healthy volunteers

    International Journal of Pharmaceutics, Vol. 67, Núm. 3, pp. 259-264

1990

  1. Decision analysis applied to selection of histamine H2-receptor antagonists for the formulary

    American Journal of Hospital Pharmacy, Vol. 47, Núm. 9, pp. 2002-2006